Skip to main content

Table 2 SAIA-HTN study primary and secondary outcomes

From: Systems analysis and improvement approach to optimize the hypertension diagnosis and care cascade for PLHIV individuals (SAIA-HTN): a hybrid type III cluster randomized trial

Type

Indicator

Numerator

Denominator

Process

BP screening*

# PLHIV in ambulatory care consults screened for BP

# Ambulatory care consults for PLHIV

HTN Diagnosis

# PLHIV with new or existing HTN diagnosis in ambulatory care consults

# PLHIV in ambulatory care consults screened for BP

HTN Medication prescribed

# PLHIV with new or existing HTN diagnosis prescribed HTN medication

# PLHIV with new or existing HTN diagnosis in ambulatory care consults

HTN Medication pick up

# PLHIV prescribed HTN medications who picked up their medications the previous month

# PLHIV with new or existing HTN diagnosis prescribed HTN medication

Clinical

Controlled HTN amongst those on treatment*

# PLHIV with new or existing HTN diagnosis and taking HTN medications who have controlled HTN

# PLHIV prescribed HTN medications who picked up their medications the previous month

Undetectable HIV viral load

# PLHIV with HTN and a non-detectable HIV viral load

# PLHIV with HTN

  1. Bolded and *= primary outcome; BP blood pressure, PLHIV people living with HIV, HIV human immunodeficiency virus, HTN hypertension